Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1093/rheumatology/ken469

Topics

  • Presentations referencing similar topics